Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Mesenchymal Stem Cells in Human Health and Diseases” book from Elsevier Science and Technology has been added to…
Conference call and webcast with ArQule management to be held on Monday, December 9, 2019 at 8:15 a.m. EST ArQule…
MILAN–(BUSINESS WIRE)–$NWRN–Newron Pharmaceutical S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies…
LONDON–(BUSINESS WIRE)–#HealthcareDevices–Technavio has been monitoring the global ophthalmology therapeutics market and the market is poised to grow by USD 9.6…
– Filing submission includes 12-month data from pivotal FIREFISH and SUNFISH trials in a broad population of people living with…
AVITA Medical secures option for exclusive licensing of emerging technologies Preclinical research will pair AVITA Medical’s Spray-On Skin™ Cells technology…
− Data presented from the pivotal Phase 3 trial include an update on overall efficacy of the vaccine candidate, as…
– ALUNBRIG Reduced the Risk of Disease Progression or Death by 76% in Patients whose Disease Had Spread to the…
Novel ways to classify patients for better treatment outcomes published in Diabetologia and Diabetes Care DUARTE, Calif.–(BUSINESS WIRE)–#CityofHope–As science continues…
National Institutes of Health has awarded the comprehensive cancer center with $8.5 million to study Li-Fraumeni Syndrome DUARTE, Calif.–(BUSINESS WIRE)–#CityofHope–Persons…